Position in INCY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$680
+$210 QoQ
Shares Held
6
+20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#828
of 854 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Addison Advisors LLC holds $20,811 across 8 Biotechnology names. INCY ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
209 | $5,741 | |
| 2 | ARGX |
Argenx SE
|
5 | $4,638 | |
| 3 | ADMA |
Adma Biologics, Inc.
|
500 | $4,185 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7 | $3,477 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 6 | INCY |
Incyte Corp
This page
|
6 | $680 | |
| 7 | CGEN |
Compugen Ltd
|
267 | $571 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
5 | $272 |
All Filings in INCY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680 | 6 | Shares | Other | 2026-08-10 | |
| 2026-03-31 | $470 | 5 | Shares | Other | 2026-05-08 | |
| 2022-12-31 | $803 | 10 | Shares | Other | 2023-02-07 | |
| 2022-09-30 | $666 | 10 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $759 | 10 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $714 | 9 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $660 | 9 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||